Both in Pharmaceuticals
Pfizer vs Abbott Laboratories
Over the past year PFE returned +20.4% and ABT returned −24.2%; their daily moves had a correlation of 0.20.
PFE +20.4% ABT −24.2%Growth of $1, one year, split-adjusted
| Metric | PFE | ABT |
|---|---|---|
| Price | $28.72 | $100.95 |
| Market cap | $163.69B | $174.68B |
| Today | 0.00% | −0.03% |
| 1 month | +2.7% | −10.2% |
| 6 months | +3.4% | −0.9% |
| Year to date | +15.3% | −19.4% |
| 1 year | +20.9% | −24.4% |
| Revenue growth (YoY) | +2.6% | +13.0% |
| Gross margin | 72.8% | 57.7% |
| Net margin | −1.6% | 7.4% |
| P/E (TTM) | 37.8× | 32.2× |
| Price / sales | 2.6× | 3.7× |
| Net cash | -$51.49B | -$27.00B |
| Dividend yield | 5.99% | 2.50% |
| Volatility (60d) | 18.6% | 29.9% |
| Short % of float | 3.2% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).